2025-01-08 2026-01-31 2026-01-31 false 16171356 CADENSYS LTD 2026-07-08 62012 false iso4217:GBP xbrli:pure 16171356 2025-01-07 16171356 2026-01-31 16171356 2025-01-08 2026-01-31 16171356 2025-01-06 16171356 2025-01-07 16171356 2025-01-07 2025-01-07 16171356 bus:SmallEntities 2025-01-08 2026-01-31 16171356 bus:AuditExempt-NoAccountantsReport 2025-01-08 2026-01-31 16171356 bus:FullAccounts 2025-01-08 2026-01-31 16171356 bus:PrivateLimitedCompanyLtd 2025-01-08 2026-01-31 16171356 core:WithinOneYear 2026-01-31 16171356 core:AfterOneYear 2026-01-31 16171356 core:WithinOneYear 2025-01-07 16171356 core:AfterOneYear 2025-01-07 16171356 core:ShareCapital 2026-01-31 16171356 core:SharePremium 2026-01-31 16171356 core:RevaluationReserve 2026-01-31 16171356 core:OtherReservesSubtotal 2026-01-31 16171356 core:RetainedEarningsAccumulatedLosses 2026-01-31 16171356 core:ShareCapital 2025-01-07 16171356 core:SharePremium 2025-01-07 16171356 core:RevaluationReserve 2025-01-07 16171356 core:OtherReservesSubtotal 2025-01-07 16171356 core:RetainedEarningsAccumulatedLosses 2025-01-07 16171356 core:LandBuildings 2026-01-31 16171356 core:PlantMachinery 2026-01-31 16171356 core:Vehicles 2026-01-31 16171356 core:FurnitureFittings 2026-01-31 16171356 core:OfficeEquipment 2026-01-31 16171356 core:NetGoodwill 2026-01-31 16171356 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 16171356 core:ListedExchangeTraded 2026-01-31 16171356 core:UnlistedNon-exchangeTraded 2026-01-31 16171356 core:LandBuildings 2025-01-07 16171356 core:PlantMachinery 2025-01-07 16171356 core:Vehicles 2025-01-07 16171356 core:FurnitureFittings 2025-01-07 16171356 core:OfficeEquipment 2025-01-07 16171356 core:NetGoodwill 2025-01-07 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-07 16171356 core:ListedExchangeTraded 2025-01-07 16171356 core:UnlistedNon-exchangeTraded 2025-01-07 16171356 core:LandBuildings 2025-01-08 2026-01-31 16171356 core:PlantMachinery 2025-01-08 2026-01-31 16171356 core:Vehicles 2025-01-08 2026-01-31 16171356 core:FurnitureFittings 2025-01-08 2026-01-31 16171356 core:OfficeEquipment 2025-01-08 2026-01-31 16171356 core:NetGoodwill 2025-01-08 2026-01-31 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-08 2026-01-31 16171356 core:ListedExchangeTraded 2025-01-08 2026-01-31 16171356 core:UnlistedNon-exchangeTraded 2025-01-08 2026-01-31 16171356 core:MoreThanFiveYears 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments 2026-01-31 16171356 core:Non-currentFinancialInstruments 2025-01-07 16171356 dpl:CostSales 2025-01-08 2026-01-31 16171356 dpl:DistributionCosts 2025-01-08 2026-01-31 16171356 core:LandBuildings 2025-01-08 2026-01-31 16171356 core:PlantMachinery 2025-01-08 2026-01-31 16171356 core:Vehicles 2025-01-08 2026-01-31 16171356 core:FurnitureFittings 2025-01-08 2026-01-31 16171356 core:OfficeEquipment 2025-01-08 2026-01-31 16171356 dpl:AdministrativeExpenses 2025-01-08 2026-01-31 16171356 core:NetGoodwill 2025-01-08 2026-01-31 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-08 2026-01-31 16171356 dpl:GroupUndertakings 2025-01-08 2026-01-31 16171356 dpl:ParticipatingInterests 2025-01-08 2026-01-31 16171356 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-08 2026-01-31 16171356 core:ListedExchangeTraded 2025-01-08 2026-01-31 16171356 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-08 2026-01-31 16171356 core:UnlistedNon-exchangeTraded 2025-01-08 2026-01-31 16171356 dpl:CostSales 2025-01-07 2025-01-07 16171356 dpl:DistributionCosts 2025-01-07 2025-01-07 16171356 core:LandBuildings 2025-01-07 2025-01-07 16171356 core:PlantMachinery 2025-01-07 2025-01-07 16171356 core:Vehicles 2025-01-07 2025-01-07 16171356 core:FurnitureFittings 2025-01-07 2025-01-07 16171356 core:OfficeEquipment 2025-01-07 2025-01-07 16171356 dpl:AdministrativeExpenses 2025-01-07 2025-01-07 16171356 core:NetGoodwill 2025-01-07 2025-01-07 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-07 2025-01-07 16171356 dpl:GroupUndertakings 2025-01-07 2025-01-07 16171356 dpl:ParticipatingInterests 2025-01-07 2025-01-07 16171356 dpl:GroupUndertakings core:ListedExchangeTraded 2025-01-07 2025-01-07 16171356 core:ListedExchangeTraded 2025-01-07 2025-01-07 16171356 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-01-07 2025-01-07 16171356 core:UnlistedNon-exchangeTraded 2025-01-07 2025-01-07 16171356 core:NetGoodwill 2026-01-31 16171356 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 16171356 core:LandBuildings 2026-01-31 16171356 core:PlantMachinery 2026-01-31 16171356 core:Vehicles 2026-01-31 16171356 core:FurnitureFittings 2026-01-31 16171356 core:OfficeEquipment 2026-01-31 16171356 core:AfterOneYear 2026-01-31 16171356 core:WithinOneYear 2026-01-31 16171356 core:ListedExchangeTraded 2026-01-31 16171356 core:UnlistedNon-exchangeTraded 2026-01-31 16171356 core:ShareCapital 2026-01-31 16171356 core:SharePremium 2026-01-31 16171356 core:RevaluationReserve 2026-01-31 16171356 core:OtherReservesSubtotal 2026-01-31 16171356 core:RetainedEarningsAccumulatedLosses 2026-01-31 16171356 core:NetGoodwill 2025-01-07 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-07 16171356 core:LandBuildings 2025-01-07 16171356 core:PlantMachinery 2025-01-07 16171356 core:Vehicles 2025-01-07 16171356 core:FurnitureFittings 2025-01-07 16171356 core:OfficeEquipment 2025-01-07 16171356 core:AfterOneYear 2025-01-07 16171356 core:WithinOneYear 2025-01-07 16171356 core:ListedExchangeTraded 2025-01-07 16171356 core:UnlistedNon-exchangeTraded 2025-01-07 16171356 core:ShareCapital 2025-01-07 16171356 core:SharePremium 2025-01-07 16171356 core:RevaluationReserve 2025-01-07 16171356 core:OtherReservesSubtotal 2025-01-07 16171356 core:RetainedEarningsAccumulatedLosses 2025-01-07 16171356 core:NetGoodwill 2025-01-06 16171356 core:IntangibleAssetsOtherThanGoodwill 2025-01-06 16171356 core:LandBuildings 2025-01-06 16171356 core:PlantMachinery 2025-01-06 16171356 core:Vehicles 2025-01-06 16171356 core:FurnitureFittings 2025-01-06 16171356 core:OfficeEquipment 2025-01-06 16171356 core:AfterOneYear 2025-01-06 16171356 core:WithinOneYear 2025-01-06 16171356 core:ListedExchangeTraded 2025-01-06 16171356 core:UnlistedNon-exchangeTraded 2025-01-06 16171356 core:ShareCapital 2025-01-06 16171356 core:SharePremium 2025-01-06 16171356 core:RevaluationReserve 2025-01-06 16171356 core:OtherReservesSubtotal 2025-01-06 16171356 core:RetainedEarningsAccumulatedLosses 2025-01-06 16171356 core:AfterOneYear 2025-01-08 2026-01-31 16171356 core:WithinOneYear 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:CostValuation 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-08 2026-01-31 16171356 core:Non-currentFinancialInstruments core:CostValuation 2026-01-31 16171356 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-01-31 16171356 core:Non-currentFinancialInstruments core:CostValuation 2025-01-07 16171356 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-07 16171356 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-07 16171356 bus:Director1 2025-01-08 2026-01-31 16171356 bus:Director2 2025-01-08 2026-01-31

CADENSYS LTD

Registered Number
16171356
(England and Wales)

Unaudited Financial Statements for the Period ended
31 January 2026

CADENSYS LTD
Company Information
for the period from 8 January 2025 to 31 January 2026

Directors | KALCK, Jean-Baptiste
| NIKAJ, Marsel

Registered Address | 128 City Road
| London
| EC1V 2NX

Registered Number | 16171356 (England and Wales)

CADENSYS LTD
Balance Sheet as at
31 January 2026

| Notes | 2026
--- | --- | ---
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 4 |  |  | 19,311
Investments | 5 |  |  | 1,396,005
|  |  |  | 1,415,316
Current assets |  |  |  |
Debtors | 6 | 253,753 |  |
Cash at bank and on hand |  | 1,015,539 |  |
|  | 1,269,292 |  |
Creditors amounts falling due within one year | 7 | (183,682) |  |
Net current assets (liabilities) |  |  |  | 1,085,610
Total assets less current liabilities |  |  |  | 2,500,926
Net assets |  |  |  | 2,500,926
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 3
Share premium |  |  |  | 3,918,962
Other reserves |  |  |  | 195,677
Profit and loss account |  |  |  | (1,613,716)
Shareholders' funds |  |  |  | 2,500,926

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 8 July 2026, and are signed on its behalf by:
KALCK, Jean-Baptiste Director Registered Company No. 16171356

CADENSYS LTD
Notes to the Financial Statements
for the period ended 31 January 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Going concern
--- | ---
| The financial statements have been prepared on a going concern basis. The directors consider this basis appropriate as the Company has sufficient cash available to continue to trade for at least 12 months from the date these financial statements are authorised for issue.

| Defined contribution pension plan
--- | ---
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the income statement in the period to which they relate.

| Share-based payments
--- | ---
| The share-based payment has been accounted for as an equity-settled transaction in accordance with FRS 102 Section 26. The fair value of the options at the grant date is recognised as an expense over the vesting period, with a corresponding credit to equity.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Straight line (years)
| Office Equipment | 3

| Investments
--- | ---
| Fixed asset investments comprise short-term deposits, bonds and other liquid investments which are readily convertible to known amounts of cash. These investments are measured at fair value, with changes in fair value and interest being recognised in the profit and loss account as they arise. Where fair value cannot be measured reliably, such investments are carried at cost less any accumulated impairment losses. These investments are held for cash-management purposes and are expected to mature within twelve months of the balance sheet date.

| Cash and cash equivalents
--- | ---
| Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.

2. | Average number of employees
--- | ---

|  | 2026
| Average number of employees during the year | 5

3. | Further information regarding the company's income
--- | ---
| These financial statements have been prepared for the period from the date of incorporation on 8 January 2025 to 31 January 2026. This represents the Company’s first set of financial statements since incorporation.

4. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 23,166 |  | 23,166
| At 31 January 26 | 23,166 |  | 23,166
| Depreciation and impairment
| Charge for year | 3,855 |  | 3,855
| At 31 January 26 | 3,855 |  | 3,855
| Net book value
| At 31 January 26 | 19,311 |  | 19,311
| At 07 January 25 | - |  | -

5. | Fixed asset investments
--- | ---
| Fixed asset investments comprise short-term deposits, bonds and other liquid investments which are readily convertible to known amounts of cash. These investments are held at fair value. The Directors have reviewed the carrying value of the investments and confirm that there are no indicators of impairment as at the balance sheet date. Accordingly, no impairment charge has been recognised in the period. The historical cost of the investments is £1,361,829.

|  | Other investments1 |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 5,323,406 |  | 5,323,406
| Revaluations | 54,635 |  | 54,635
| Disposals | (3,982,036) |  | (3,982,036)
| At 31 January 26 | 1,396,005 |  | 1,396,005
| Net book value
| At 31 January 26 | 1,396,005 |  | 1,396,005

| Notes
--- | ---
| 1Other investments other than loans

6. | Debtors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Other debtors | 250,154
| Prepayments and accrued income | 3,599
| Total | 253,753

7. | Creditors: amounts due within one year
--- | ---

|  | 2026
--- | --- | ---
|  | £
| Trade creditors / trade payables | 4,512
| Bank borrowings and overdrafts | 52,218
| Taxation and social security | 108,569
| Other creditors | 4,482
| Accrued liabilities and deferred income | 13,901
| Total | 183,682

| At the balance sheet date, the Company owed £593 to a Director and this amount is included within other creditors. This loan is unsecured, interest free and repayable on demand.

8. | Operating lease commitments
--- | ---
| At the balance sheet date, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £19,847 being due within one year.

9. | Further information regarding the company's financial position
--- | ---
| During the period, the company established an equity-settled share option scheme to incentivise key employees and consultants. Under the plan, 214,262 options were granted over 4 years with an exercise price of £0.000001. The fair value of the options have been valued at £6.726718 based on the March 2025 funding round. The value of the options that vested in the year was £195,677 and this was charged to the profit and loss account as an expense. 25,884 options were forfeited during the period and no options were exercised or expired during the period. The total carrying amount is £195,677 has been recognised in Other Reserves. The total number of shares options outstanding at the year end is 188,378.